M12 Stock Overview
Provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
M1 Kliniken AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €17.85 |
| 52 Week High | €22.70 |
| 52 Week Low | €7.30 |
| Beta | 1.18 |
| 11 Month Change | -15.00% |
| 3 Month Change | 43.37% |
| 1 Year Change | 123.13% |
| 33 Year Change | 70.00% |
| 5 Year Change | 32.22% |
| Change since IPO | 256.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| M12 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -0.3% | -1.5% | 0.09% |
| 1Y | 123.1% | 0.8% | 3.1% |
Return vs Industry: M12 exceeded the German Healthcare industry which returned 0.8% over the past year.
Return vs Market: M12 exceeded the German Market which returned 3.1% over the past year.
Price Volatility
| M12 volatility | |
|---|---|
| M12 Average Weekly Movement | 10.1% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: M12's share price has been volatile over the past 3 months.
Volatility Over Time: M12's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 219 | Kilian Brenske | www.m1-kliniken.de |
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin.
M1 Kliniken AG Fundamentals Summary
| M12 fundamental statistics | |
|---|---|
| Market cap | €328.75m |
| Earnings (TTM) | €10.27m |
| Revenue (TTM) | €316.32m |
32.0x
P/E Ratio1.0x
P/S RatioIs M12 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| M12 income statement (TTM) | |
|---|---|
| Revenue | €316.32m |
| Cost of Revenue | €283.85m |
| Gross Profit | €32.47m |
| Other Expenses | €22.20m |
| Earnings | €10.27m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.56 |
| Gross Margin | 10.27% |
| Net Profit Margin | 3.25% |
| Debt/Equity Ratio | 3.8% |
How did M12 perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield93%
Payout RatioDoes M12 pay a reliable dividends?
See M12 dividend history and benchmarks| M1 Kliniken dividend dates | |
|---|---|
| Ex Dividend Date | Jul 18 2024 |
| Dividend Pay Date | Jul 22 2024 |
| Days until Ex dividend | 20 days |
| Days until Dividend pay date | 24 days |
Does M12 pay a reliable dividends?
See M12 dividend history and benchmarks